Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | RIVN | TSLA |
|---|---|---|
| Price | $14.80 | $356.22 |
| Change today | ▼ 0.94% | ▲ 0.40% |
| Market cap | $21.43B | $1.41T |
| Return, 3 months | -13.9% | -16.2% |
| Return, year to date | -24.9% | -20.8% |
| Return, 1 year | +1.3% | -22.5% |
| P/E (TTM) | -5.7 | 329.8 |
| P/B | 4.2 | 16.2 |
| P/E percentile vs own 5y | 9th | 86th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +27.2% | +25.5% |
| Net profit growth (YoY) | +24.9% | -5.2% |
| Gross margin | 7.5% | 18.9% |
| Operating margin | -60.1% | 4.6% |
| Net margin | -55.0% | 3.7% |
| Return on equity | -57.9% | 4.6% |
| Analyst target vs. price | +26.7% | +17.3% |
| Analyst buy share | 42% | 50% |
| RSI (14) | 42 | 46 |
| 30-day volatility | 40.9% | 44.9% |
| Max drawdown, 1 year | -42.5% | -39.1% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
